top of page

Can HRT Enhance Weight Loss with Tirzepatide (Mounjaro) in Postmenopausal Women?

Alternative Therapies, Diet, HRT, Managing Weight

At ENDO 2025 in San Francisco, an important study was presented exploring the effect of hormone replacement therapy (HRT) on weight loss in postmenopausal women taking tirzepatide (Mounjaro), a medication licensed for the management of type 2 diabetes and obesity.

What Was the Study About?

The real-world, retrospective cohort study looked at 120 postmenopausal women who were prescribed tirzepatide for overweight or obesity.

  • 40 women were also taking HRT (either transdermal or oral oestrogen, with or without progestogen).

  • 80 were on tirzepatide alone.

    Participants were followed over a median of 18 months.


What Were the Results?

Women who were taking both HRT and tirzepatide had:

✔️ A greater median percentage weight loss (17% vs 14%)

✔️ A higher rate of achieving 20%+ weight loss (45% vs 18%)

These findings suggest that concomitant HRT may positively influence weight loss response when using incretin-based therapies like tirzepatide.

However, as with all retrospective studies, we must interpret the findings cautiously. These are associations—not proven cause and effect—and more robust research is needed to understand the biological mechanisms involved.


Prescribing Considerations

The British Menopause Society (BMS) has issued guidance on using oral HRT alongside medications like tirzepatide or semaglutide (Wegovy). These treatments can slow gastric emptying, which may interfere with the absorption of oral progestogens. This can potentially lead to insufficient endometrial protection in women with a uterus, increasing the risk of unscheduled bleeding or endometrial hyperplasia.

To mitigate this, clinicians may consider prescribing:

  • Transdermal oestrogen

  • Alongside a non-oral progestogen (e.g., micronised progesterone or an intrauterine system), especially in patients on GLP-1 receptor agonists or GIP/GLP-1 dual agonists like tirzepatide.


Supporting Womens Health with Personalised Care

At Bristol Menopause & Wellwoman Clinic, we support women navigating the complex relationship between weight, hormones, and menopause. Whether you're struggling with weight changes, perimenopausal symptoms, or looking for medically supervised weight management, we're here to help.


 Want to explore your options?

Our team includes menopause specialists, weight loss clinicians, and prescribing experts who can create a plan tailored to you.


Book a consultation today

Contact us here

Get in Touch

If you would like a personal Wellwoman Check, or are suffering from any of the symptoms of the menopause and would like to learn more, please head to our contact page to book an appointment. 

You'll be so glad you did!

0117 452 5747 (office hours: 9am to 5pm) 

Low Barn, Sheepway, Portbury, Bristol, BS20 7TF 

Bristol Health Hub Logo_Landscape.png
Blue transparent.png
Menopause By Hazel_png_black.png
128-0-0-0-10000-10000-96.jpg
58-0-69-0-9550-10000-128.png
25-0-0-2494-10000-4396-153.jpg
54-0-0-0-10000-10000-128.png
  • LinkedIn
  • Instagram
  • Facebook
Colour.png
Bristol Menopause Logo_navy (1).png
55-0-0-0-10000-9390-128.jpg
General-Medical-Council.png

Join our mailing list

Bristol Menopause Limited | Company No: 13030255 | Registered Office: 4 King Square, Bridgewater, Somerset TA6 3YF 

The Bristol Menopause & Wellwoman Clinic is regulated by the Care Quality Commission - Reg. No: 12245877078. 

bottom of page